Viewing StudyNCT02252107



Ignite Creation Date: 2024-05-06 @ 3:18 AM
Last Modification Date: 2024-10-26 @ 11:31 AM
Study NCT ID: NCT02252107
Status: COMPLETED
Last Update Posted: 2020-03-19
First Post: 2014-09-19

Brief Title: 10-day Decitabine Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1
Sponsor: Radboud University Medical Center
Organization: Radboud University Medical Center

Conditions & Keywords Data

Conditions:
Name
Acute Myeloid Leukemia AML
Keywords:
Name View
Decitabine View
Hematopoietic stem cell transplantation HSCT View
Conditioning View
AML View